Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1130320110540040157
Korean Journal of Pediatrics
2011 Volume.54 No. 4 p.157 ~ p.162
Alteration of CD4+CD25+Foxp3+ T cell level in Kawasaki disease
Sohn Su-Ye

Song Young-Wooh
Yeo Yun-Ku
Kim Yun-Kyung
Jang Gi-Young
Woo Chan-Wook
Lee Jung-Hwa
Lee Kwang-Chul
Abstract
Purpose : Exaggerated pro-inflammatory reactions during the acute phase of Kawasaki disease (KD) suggest the role of immune dysregulation in the pathogenesis of KD. We investigated the profiles of T regulatory cells and their correlation with the clinical course of KD.
Methods : Peripheral blood mononuclear cells were collected from 17 KD patients during acute febrile and subacute afebrile phases. T cells expressing CD4, CD25, and Foxp3 were analyzed using flow cytometry, and the results were correlated with the clinical course of KD.

Results : The percentage of circulating CD4+CD25highFoxp3+ T cells among CD4+ T cells was significantly higher during the subacute afebrile phase than during the acute febrile phase (1.10%¡¾1.22% vs. 0.55%¡¾0.53%, P=0.049). Although levels of CD4+CD25lowFoxp3+ T cells and CD4+CD25?Foxp3+ T cells were only slightly altered, the percentage of CD4+CD25+Foxp3? T cells among CD4+ T cells was significantly lower during the subacute afebrile phase than during the acute febrile phase (2.96%¡¾1.95% vs. 5.64%¡¾5.69%, P=0.036). Consequently, the ratio of CD25highFoxp3+ T cells to CD25+Foxp3? T cells was higher during the subacute afebrile phase than during the acute febrile phase (0.45%¡¾0.57% vs. 0.13%¡¾0.13%, P=0.038).

Conclusion : Decreased CD4+CD25highFoxp3+ T cells and/or an imbalanced ratio of CD4+CD25highFoxp3+ T cells to CD4+CD25+ Foxp3? T cells might play a role in KD development. Considering that all KD patients were treated with intravenous immunoglobulin (IVIG), recovery of CD4+CD25highFoxp3+ T cells during the subacute afebrile phase could be a mechanism of IVIG.
KEYWORD
Kawasaki disease, Regulatory T cell, CD25+, Foxp3+
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø